Viewing StudyNCT00004198



Ignite Creation Date: 2024-05-05 @ 11:07 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004198
Status: COMPLETED
Last Update Posted: 2023-12-27
First Post: 2000-01-21

Brief Title: Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkins Lymphoma
Sponsor: University of Nebraska
Organization: University of Nebraska

Organization Data

Organization: University of Nebraska
Class: OTHER
Study ID: 0196-99-FB
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Nebraska
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Genitope Corporation INDUSTRY
National Cancer Institute NCI NIH